Skip to main content
Search
Explore journals
Get published
About BMC
My account
Search all BMC articles
Search
BMC Cancer
Home
About
Articles
Submission Guidelines
Collections
Join the Board
Submit manuscript
Article metrics
Last updated: Mon, 6 May 2024 9:39:21 Z
The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131